Peptide directoryHeart, vessels & kidneys

Intermedin

A second adrenomedullin found in 2004, with a liking for the placenta and the heart.

Where it comes from

Made in
Pituitary, gut, placenta, heart, kidney
Sent out by
Hypoxia and pregnancy raise it
Acts on
  • Blood vessels
  • Heart muscle
  • Placenta
  • Hypothalamus

What it does

  • Lowers blood pressure and strengthens the heartbeat in animals 1
  • Takes part in placental vessel growth and in how the trophoblast handles immune recognition 2
  • Reduces food intake when given into the brain of a rat 1

In medicine

  • No medicine and no test. Levels come from research assays that do not separate it cleanly from adrenomedullin 1
  • A weakened intermedin system is reported in pre-eclampsia and in fetal growth restriction, from placental and plasma studies rather than from trials 2
  • Because it works through the same receptors as adrenomedullin and CGRP without preferring any of them, anything built on it would hit all three; that is one reason no programme has started 1

Beyond the body’s own use

  • It protects the heart, kidney and lung vessels in rodent models of heart attack, kidney injury and pulmonary hypertension. No human trial has been registered
  • The appetite claims come from brain injections in rats; nothing has been tested in a person, and the dose that reduces feeding also drops blood pressure 1
  • The open question is whether it does anything in an adult that adrenomedullin does not. It was found by searching a genome for relatives rather than by chasing an effect, and that order still shows 1

Sources

  1. Roh et al., Intermedin is a calcitonin/CGRP family peptide acting through calcitonin receptor-like receptor complexes, Journal of Biological Chemistry 2004
  2. Chauhan et al., Adrenomedullin 2/intermedin regulates HLA-G in human trophoblasts, Biology of Reproduction 2011

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.